Real-world cohort demonstrates safety and effectiveness of CAR T-cell therapy for patients with R/R multiple myeloma, including those who might not have met fitness criteria for some other treatments and trialsRead More
Genetic Advances Fuel New Hope in Fight Against Myeloid Leukemias
Cleveland Clinic researchers have identified genetic mutations in a subset of leukemia patients. The mutations potentially can be targeted with drugs, introducing the prospect of personalized treatments for these cancers.
Clinical Trial Assesses Next-Generation Cancer Genomic Test
Cleveland Clinic oncologists are evaluating a genomic test that looks for 236 genes implicated in cancer. A key question the clinical study will try to answer is how well the broad genomic screen works in real-world settings.